For all skin type
States may apply reasonable service limits based on medical necessity or to control utilization, but once covered, services must be sufficient in amount, duration and scope to reasonably achieve their purpose. 38 , 39 There are additional protections and flexibilities for children and youth up to age 21 40 under the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT)
[Accessed 16 June 2026] Wharton S and others
As GLP-1 receptor agonists gain wider use for metabolic disease and weight management, dermatologists, primary care clinicians, researchers, and patients are seeking clear information about possible cutaneous effects, rare adverse events, and potential therapeutic interactions
Holman RR, Paul SK, Bethel MA, et al